Company intelligence
PhaseV
Adaptive. Causal. Intuitive.
About PhaseV
PhaseV is a Boston-based technology company transforming clinical development with an enterprise-ready AI/ML platform that accelerates decisions, de-risks trials, and drives portfolio efficiency. Its Trial Optimizer designs smarter studies, reducing costs by up to 50%, lowering enrollment needs by 40%, shortening timelines by 40%, and boosting probability of success by 30%+. The ClinOps Optimizer enhances site selection by integrating patient-level insights with real-time dashboards to track performance. The Lifecycle Management module combines causal evidence, development complexity, and market value to inform portfolio decisions. Together, these solutions enable sponsors and CROs to optimize every stage of development.
Verified activity
Signals from PhaseV
6 published signals
Presence & Recognition
PhaseV is organizing the RISW 2026 session on agentic AI in regulatory science featuring three leaders from JHU, FDA, and Takeda.
Reported by Brad Carlin
Presence & Recognition
PhaseV Booth 512 will host a presentation by Hamza Sheikh on accelerating clinical development from synopsis to CSR using a human-guided AI workflow at DPHARM2026 on September 15 at 11:35 a.m. to 11:45 a.m. in Constitution B.
Reported by PhaseV
Presence & Recognition
PhaseV is attending the World Medical Innovation Forum in Boston from September 22 to 23 to discuss clinical development and AI applications.
Reported by PhaseV
Presence & Recognition
PhaseV is exhibiting at Booth 12 at RISW 2026 in Rockville from September 16 to 18.
Reported by PhaseV
Presence & Recognition
PhaseV is attending the 2026 CDISC TechniCon on 9 September 2026.
Reported by PhaseV
Presence & Recognition
PhaseV is speaking at DPHARM2026 to walk through how PhaseV is bringing intelligent, end-to-end orchestration and optimization to the clinical trial journey powered by causal AI and agentic workflows.
Reported by Hamza Sheikh